Guobang Pharmaceutical (605507): Repurchase shares to launch employee stock ownership plan, prices of major products have bottomed out
Guobang Pharmaceutical (605507): Active repurchases show confidence in long-term development
Guobang Pharmaceutical (605507): Competition in the mobile insurance sector is intensifying and profitability is expected to gradually improve
Guobang Pharmaceutical (605507): Veterinary drug prices are expected to bottom out, and the company's performance is expected to gradually improve
Guobang Pharmaceutical (605507): Sales volume of core varieties is growing steadily, and the leading position of APIs continues to be stable
Guobang Pharmaceutical (605507): Under pressure from the pharmaceutical intermediates and active pharmaceutical APIs business, net profit of the return mother decreased 28% year-on-year in the first half of the year
Guobang Pharmaceutical (605507): Cost advantages help the company grow against adversity
Guobang Pharmaceutical (605507) 2022 Report and 2023 Quarterly Report Reviews: Net profit of the 22-year return mother +30% compared to the previous year, and the gross margin of the 23Q1 mobile insurance sector bucked the trend
Guobang Pharmaceutical (605507): The pharmaceutical sector is growing steadily and the insurance business is rapidly expanding
Guobang Pharmaceutical (605507) 2022 Report Review: Pharmaceutical and Animal Insurance Sectors Expand, and the Competitiveness of the Pharmaceutical Manufacturing Industry Chain Continues to Strengthen
Guobang Pharmaceutical (605507): Product Quality Matrix, Rich Categories, Expanding Performance
Guobang Pharmaceutical (605507) In-depth Report: The Performance of Leading Veterinary Chemical Companies Is Growing Rapidly
Guobang Pharmaceutical (605507) Company's First Coverage Report: Pharmaceutical and Animal Insurance Two-wheel Drive Entered a Period of Rapid Development
Guobang Pharmaceutical (605507): An integrated platform enterprise for pharmaceutical and animal insurance high-end manufacturing with steady growth
Guobang Pharmaceutical (605507): Expansion of production combined with rising pig prices is optimistic about the release of health insurance performance
Guobang Pharmaceutical (605507): production capacity to help improve the performance of high-quality pharmaceutical enterprises
Guobang Medicine (605507): platform casting advantages and novelty
No Data